The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Wed., Mar. 3, 10:51 PM

Slide #63. Terumo Corporation Health Outcomes Sciences, Inc.

Acquirer: Terumo Corporation (TRUMY)
Acquiree: Health Outcomes Sciences, Inc.
Details: Terumo Corporation (TSE: 4543), a global leader in medical technology, has signed a definitive agreement to acquire all assets of Health Outcomes Sciences, Inc. (HOS). HOS specializes in predictive analytics and clinical decision support that enable healthcare organizations to deliver personalized, predictive insights at the point of care, resulting in significant and measurable improvements in clinical, patient and financial outcomes.

  Terumo Corporation: TRUMY
  Health Outcomes Sciences, Inc.: PRIVATE
 

Open the DAN Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.29 out of 4)
45th percentile
(ranked lower than approx. 55% of all stocks covered)

Analysts' Target Price:
DAN Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.